14th European Congress of Clinical Microbiology and Infectious ...

Small
Hall
Integrated Symposia
Scientific Programme Monday, May 3, 2004
Acute exacerbation of chronic bronchitis
(AECB): an insidious infection
Chairpersons: Francesco Blasi (Milan, I)
Antoni Torres (Barcelona, E)
10:00 Introduction
S214 Epidemiology features: regional aspects and
10:05 patient challenges
Rafael Canton (Madrid, E)
S215 PK/PD features for optimisation of antibiotic
10:30 therapy
Johan W. Mouton (Nijmegen, NL)
S216 AECB management: state of the art –
10:55 new European guidelines
Antoni Torres (Barcelona, E)
S217 AECB: therapeutic options
11:20 Hartmut Lode (Berlin, D)
11:45 Summary, conclusions & discussion
South
Hall
Integrated symposium arranged by
Aventis Pharma
New strategies in the management of fungal
infections
Chairpersons: David W. Denning (Manchester, UK)
Jo-Anne H. van Burik
(Minneapolis, USA)
10:00 Welcome and introduction
David W. Denning (Manchester, UK)
S218 Review of echinocandin antifungal drugs
10:05 David W. Denning (Manchester, UK)
S219 Clinical pharmacokinetics of micafungin
10:25 Nasrullah A. Undre (Munich, D)
S220 Micafungin for prophylaxis of fungal
10:50 infections in high-risk patients
Jo-Anne H. van Burik (Minneapolis, USA)
S221 Fungal infections in paediatrics –
11:10 new perspectives
Frank-Michael Müller (Heidelberg, D)
11:30 Panel discussion
11:55 Concluding remarks
David W. Denning (Manchester, UK)
Integrated symposium arranged by Fujisawa
Forum
Hall
Effective use of carbapenems in the
management of hospitalised patients with
community-acquired infections
Chairperson: Gert Höffken (Dresden, D)
10:00 Opening remarks
Gert Höffken (Dresden, D)
S222 Role of ertapenem in the evolving
10:05 management of CAP
Gert Höffken (Dresden, D)
S223 Ertapenem: effective and appropriate
10:35 antimicrobial therapy for intra-abdominal
infections
Christina Chan (Whitehouse Station, USA)
S224 Carbapenems in an era of antibiotic resistance
10:55 George Karam (Baton Rouge, USA)
S225 How will ertapenem affect the resistance
11:20 ecology?
David Livermore (London, UK)
11:45 Panel discussion
11:55 Conclusion
Gert Höffken (Dresden, D)
Meeting
Hall V
Integrated symposium arranged by
Merck, Sharp & Dohme
Macrolides and inflammation modulation in
respiratory tract infections
Chairpersons: Guy W. Amsden (Cooperstown, USA)
Thomas M. File (Akron, USA)
S226 Immunomodulatory effects of macrolides
10:00 Ognjen Culic (Zagreb, HR)
S227 Biphasic modulation by azithromycin
10:30 of human neutrophil function:
implications for therapy
Michael J. Parnham (Zagreb, HR)
S228 Macrolides and inflammation modulation in
11:00 the treatment of respiratory tract infections
Guy W. Amsden (Cooperstown, USA)
S229 Clinical use of macrolides in the treatment of
11:30 RTIs: focus on azithromycin
Thomas M. File (Akron, USA)
Integrated symposium arranged by Pliva
www.escmid.org/eccmid2004 page 47